In this episode, we look at a life sciences instrumentation company in the genome analysis space called Bionano Genomics (BNGO.Q). The company develops and markets the Saphyr system, a…
Search Results for: bngo
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Bionano Genomics operates as a life sciences instrumentation company in the genome analysis space that provides tools and services based on their Saphyr system to scientists and clinicians conducting…
Bionano Genomics (BNGO.Q) has been keeping busy lately, and the Company’s Q2 2021 Financial Results are a testament to their efforts. Bionano has been on my radar for…
Bionano Genomics (BNGO.Q) is a disruption play. The company is a structural variation company focusing on the next generation of cytogenomics with optical genome mapping. For in…
Bionano Genomics (BNGO.Q) has released a summary of results obtained by the University Hospitals Leuven, Belgium utilizing Saphyr® System, the Company’s Optical Genome Mapping (OGM) platform. The work completed…
Bionano Genomics (BNGO.Q) announced today that optical genome mapping (OGM), utilizing the Company’s Saphyr System, has revealed new insights and prognostic capabilities compared to traditional cytogenetics techniques in several…
Bionano Genomics (BNGO.Q) announced today that it has made significant progress in China with the adoption of its Saphyr System for optical genome mapping (OGM) by WeHealth Shanghai, a…
Bionano Genomics (BNGO.Q), a genome analysis company providing tools and services to scientists and clinicians, announced today that it has been added as a member of the US small-cap…
Bionano Genomics (NASDAQ:BNGO) saw its shares surge 22% on Monday after the Company announced the hiring of its new Chief Commercial Officer, Jason Priar. Read full article here: https://equity.guru/2021/06/08/bionano-genomics-nasdaqbngo-shares-soar-investors-going-bananas-for-bngo/…